AlphAIAlphAI — Financial news for AI agents
marketscreener.comOCT 211 min read$CME

CME Group Q3 Adjusted Earnings, Revenue Rise

CME Group reported Q3 adjusted earnings of $3.02 per share, beating FactSet estimates of $2.99. Revenue also increased. The company's stock has risen 6.22% year-to-date and 8.14% over the past year. Investors may find these results relevant for trading decisions.

Original reporting
marketscreener.com
Published Oct 21, 2026, 11:25 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CME
Bullish
high confidence
Mentioned
$CME
Relevance
8/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

The earnings beat may trigger buying interest and lift related exchange‑traded product stocks.

02

Market read

CME's better‑than‑expected earnings could lift financial‑services equities and set tone for the day's market open.

03

What to watch

Guidance outlook and margin trends were not disclosed, which could temper upside.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

CME Group is a leading derivatives exchange operator; its earnings are a key barometer for the broader financial‑services sector.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group reported Q3 adjusted EPS of $3.02, topping the FactSet estimate of $2.99.

Expected impact

likely upward pressure as the market prices in the earnings beat.

Evidence & confidence

The beat is a fresh primary disclosure for a large‑cap exchange operator; traders typically react positively to better‑than‑expected earnings.

Market effects

Sector

May boost sentiment for financial services and exchange‑traded product providers.

Regional

U.S. markets could open higher on the earnings surprise.

Global

CME's results are watched globally; a beat can influence other derivatives exchanges.

Counterpoint

What could challenge this read

If the beat is already priced in, the stock could face short‑covering pull‑back.

Key entities

  • company
    CME Group Inc.

    U.S.-listed derivatives exchange operator.

Read at source← All news

StoryCME Group posts record Q3 revenue and adjusted EPS beat, but shares dip on guidance concerns

Also covered by

6 outlets

Related articles

OCT 21
$CMEHighAI 8/10

CME: 3Q 2026 Intro Script

CME Group reported record Q3 2026 earnings with $1.7B revenue (up 13% YoY) and $3.02 EPS (up 13% YoY). ADV reached 29.4M contracts (up 16% YoY), with strong growth across all asset classes. Open interest hit 128M contracts, and international volume grew 22%. The company launched new products and plans to migrate markets to Google Cloud by late 2027.

marketscreener.com3 min
OCT 21
$CMEHighAI 9/10

CME: 3Q 2026 Income Statement Trend

CME Group Inc. reported financial data for Q3 2026, showing total revenues of $1,737.3 million and net income of $1,036.9 million. Operating income was $1,141.4 million with an operating margin of 66%. Basic and diluted EPS were $2.90 and $2.89 respectively.

marketscreener.com2 min
OCT 21
$CMEMed

CME Group (CME) Shares Slip Despite Strong Q3 Results; Dividend

CME Group (CME) shares fell 1.2% premarket despite Q3 earnings and revenue beating estimates. Adjusted EPS was $3.02 on revenue of $1.74B, but expenses rose to $595.9M. The dividend yield is 4.04% with a high payout ratio of 95% and negative 3-year dividend growth. CME's GF Score is 88/100, indicating strong fundamentals but financial strength concerns.

gurufocus.com2 min